Track the 바텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바텍 has recorded 19 public disclosures. Market capitalisation: €270.9bn. The latest transaction was disclosed on 11 March 2026 (Other). Among the most active insiders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨. Every trade is free.
16
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Fundamental score
Ranked 786 of 29,064 companies
82.5
score / 100
Value
93
Quality
72
FCF yld18%
Earn yld15%
EV/EBITDA4.2x
ROE·
Gross mgn52%
Net mgn9.4%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
바텍 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo y la fabricación de soluciones innovadoras para el diagnóstico médico.